These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9841230)

  • 1. Low response to hepatitis B vaccine in health care workers and medical students in Lisbon, Portugal.
    Marinho RT; Ramalho F; Velosa J
    Hepatology; 1998 Oct; 28(4):1166. PubMed ID: 9841230
    [No Abstract]   [Full Text] [Related]  

  • 2. Low response to hepatitis B virus vaccine in Costa Rican health-care workers.
    Taylor L; García Z; Herrera G; Luftig RB; Visona KA
    Hepatology; 1998 Feb; 27(2):637. PubMed ID: 9462669
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness to intradermal recombinant hepatitis B vaccine.
    CDR (Lond Engl Wkly); 1991 Oct; 1(43):198. PubMed ID: 1669886
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies against hepatitis B after vaccination in health workers].
    Pérez-López JA; García-Elorriaga G; Del Rey-Pineda G; Manjarrez-Téllez B
    Salud Publica Mex; 2011; 53(3):205-6. PubMed ID: 21829884
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonresponders to hepatitis B vaccine.
    Jenson HB
    Postgrad Med; 2000 Mar; 107(3):97-8. PubMed ID: 10728138
    [No Abstract]   [Full Text] [Related]  

  • 9. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

  • 11. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to hepatitis B vaccination in high risk population.
    Prakash C; Bhatia R; Kumari S; Verghese T; Datta KK
    J Commun Dis; 2000 Mar; 32(1):17-21. PubMed ID: 11129560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral response and genetic stability of recombinant BCG expressing hepatitis B surface antigens.
    Rezende CA; De Moraes MT; De Souza Matos DC; McIntoch D; Armoa GR
    J Virol Methods; 2005 Apr; 125(1):1-9. PubMed ID: 15737410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.
    Sangfelt P; Uhnoo I; Reichard O; Weiland O
    Scand J Gastroenterol; 2008; 43(4):465-72. PubMed ID: 18365912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the immunizing potency of hematogenic hepatitis B vaccine].
    Kang P
    Zhonghua Hu Li Za Zhi; 1993 Nov; 28(11):643-5. PubMed ID: 8124773
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
    Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
    Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation.
    Berner J; Kadian M; Post J; Miller C; Schwartz M; Conn M; Borcich A
    Transplant Proc; 1993 Apr; 25(2):1751-2. PubMed ID: 8470152
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigens in hepatitis B vaccines.
    Mital N
    Indian Pediatr; 2001 Jul; 38(7):797. PubMed ID: 11463972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.